Market Access South Korea: Emerging global leader in life sciences South Korea has designated life sciences and biotechnology as priority areas for growth and leadership.
Market Access China’s 4+7 drug procurement policy and its impact on the ph... It is estimated that China has around 10,000 pharmaceutical companies varying in size, strategy, and technology.
News Project seeks to shape digital health reimbursement in APAC APACMed and Eversana join forces to draw up coverage frameworks applicable to APAC countries.
Oncology Country focus: China & APAC’s growing medical needs bring op... Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
